DOI: http://dx.doi.org/10.18203/2349-3933.ijam20193298

A rare case of blood stream infection due to Candida ciferii in an immuno-compromised patient

Sonali Choudhari, Swati Kale, Anand Pathak, Pradeep Mishra, Girish Deshpande

Abstract


Invasive infections related to yeast are increasingly observed in immune-compromised patients in hospitals.Fungal infections have increased morbidity and mortality and prolonged hospital stay which can lead to rise in medical care costs. Non-albicans Candida species have been increasingly found as causative agents in human infections with important therapeutic implications. We present a case of a 37-year-old, female patient, known case of B cell Acute Lymphoblastic Leukaemia admitted in a tertiary care hospital in central India for supportive care and chemotherapy. Patient was responding well to chemotherapy. On post induction day 20, she complained of high-grade fever with abdominal pain.Two sets of blood culture were sent to Microbiology Diagnostic Laboratory for diagnosis. She was started on Injection Magnex Forte (Cefoperazone-Sulbactum) empirically.The Gram stain of positive blood culture showed Gram positive budding yeast like cells in all four bottles.The organism was identified as C. ciferrii on Vitek 2 with 95% identification.Antibiotic susceptibility testing showed sensitive to Amphotericin B MIC ≤0.25 and voriconazole MIC ≤0.12. It was resistant to fluconazole MIC ≥64 μg/ml.


Keywords


Acute lymphoblastic Leukaemia, Candida cifferi, Febrile neutropenia

Full Text:

PDF

References


Gunsilius E, Lass-Flörl C, Kähler CM, Gastl G, Petzer AL. Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients. Ann Hematol. 2001;80(3):178-9.

García-Martos P, Ruiz-Aragón J, García-Agudo L, Saldarreaga A, Lozano MC, Marín P. Candida ciferrii in an immunocompromised patient. Ibero-Am J Mycol. 2004;21(2):85-6.

Villanueva-Lozano H, Treviño-Rangel RD, Hernández-Balboa CL, González GM, Martínez-Reséndez MF. An unusual case of Candida ciferrii fungemia in an immunocompromised patient with Crohn’s and Mycobacterium bovis disease. J Infection Developing Countries. 2016;10(10):1156-8.

Sobel JD. The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia. Current Inf Dis Rep. 2006;8(6):427-33.

Kreger-van Rij NJ. Candida ciferrii, a new yeast species. Mycopathol. 1965;26(1):49-52.

Saha KNK, Sit AM. Recovery of fluconazole sensitive Candida ciferrii in a diabetic chronic obstructive pulmonary disease patient presenting with pneumonia. Lung India: Official Organ of Ind Chest Soc. 2013;30(4):338.

Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev. 1995;8:462-78.

Rubin Grandis J, Branstetter BF, Yu VL. The changing face of malignant (necrotising) external otitis: Clinical, radiological, and anatomic correlations. Lancet Infect Dis. 2004;4:34–9. 11.

Agın H, Ayhan Y, Devrim I, Gülfidan G, Tulumoglu Ş, Kayserili E. Fluconazole-, amphotericin-B-, caspofungin-, and anidulafungin-resistant Candida ciferrii: an unknown cause of systemic mycosis in a child. Mycopathol. 2011;172(3):237-9.

Upadhyay S, Wadhwa T, Sarma S. A Series of Six Cases of Candida Ciferrii Infection in a Tertiary Care Centre of North India. J Adv Med Med Res. 2018:1-5.

Villanueva-Lozano H, de Trevino-Rangel RJ, Hernandez-Balboa CL, Gonzalez GM, Martinez-Resendez MF. An unusual case of Candida ciferrii fungemia in an immunocompromised patient with Crohn’s and Mycobacterium bovis disease. J Infect Dev Ctries 2016; 10(10):1156-1158.

De Gentile L, Bouchara JP, Cimon B, Chabasse D. Candida ciferrii: clinical and microbiological features of an emerging pathogen: Candida ciferrii: Clinical and microbiological characteristics of a pathogen of increasing importance. Mycoses. 1991;34(3‐4):125-8.

Capoor MR, Gupta DK, Verma PK, Sachdeva HC. Rare yeasts causing fungemia in immunocompromised and haematology patients: case series from Delhi. Ind J Med Microbiol. 2015;33(4):576.

Gunsilius E, Lass-Flörl C, Kähler CM, Gastl G, Petzer AL. Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients. Anna Hematol. 2001;80(3):178-9.